Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

ConditionAdvanced Gastric Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorChanghai Hospital

About this trial

This study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT capsules combined with chemotherapy and anti-PD1/PDL1 therapy in the advanced gastric cancer.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Fecal Microbiota Transplantation Capsules
Placebo

Treatment groups

124 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Changhai Hospital

Lead sponsor

Source ClinicalTrials.gov